Endogenous metabolic enzymes and transporters for amino acids, glucose, and fatty acids

Endogenous metabolic enzymes and transporters for amino acids, glucose, and fatty acids represent a comprehensive functional category of proteins that facilitate the movement and biochemical processing of primary metabolic substrates. This group encompasses a wide array of molecular entities, including solute carrier (SLC) transporters for glucose (e.g., GLUT1, SGLT2) and amino acids (e.g., LAT1), as well as key regulatory enzymes in glycolysis, the tricarboxylic acid cycle, and lipid metabolism (NIH, 2021; UniProt, 2023). These proteins are essential for maintaining cellular energy balance, supporting growth through the provision of biosynthetic precursors, and regulating systemic metabolic health. Dysregulation of these pathways is a primary driver of metabolic diseases such as type 2 diabetes and obesity, and it plays a critical role in the survival and proliferation of cancer cells through metabolic reprogramming (Nature Reviews Cancer, 2011; PubMed, 2020). Numerous blockbuster drugs target specific components of this system, including statins for cholesterol management and SGLT2 inhibitors for diabetes (StatPearls, 2023). However, because these metabolic processes are fundamental to nearly all cell types, therapeutic intervention requires high specificity to minimize the risk of systemic toxicity and off-target effects (PubMed, 2020).

Other names

Metabolic enzymes and transportersNutrient transportersMetabolic pathway proteinsSubstrate transporters and enzymes

Drugs targeting these proteins typically act by inhibiting specific transporters to reduce nutrient absorption or reabsorption, or by modulating the activity of rate-limiting enzymes to alter metabolic flux and restore homeostatic levels of glucose, lipids, or amino acids.